PDCD1 and metastatic melanoma: Monoclonal antibodies (mAbs) able to block the immune checkpoints cytotoxic T-lymphocyteantigen-4 (CTLA-4), programmed cell death protein 1 (PD-1) and its ligand (PD-L) havedemonstrated high activity in metastatic melanoma and other solid tumors.